Cargando…
Development and External Validation of a Nomogram to Predict Recurrence-Free Survival After R0 Resection for Stage II/III Gastric Cancer: An International Multicenter Study
Background: The benefit of adjuvant chemotherapy varies widely among patients with stage II/III gastric cancer (GC), and tools predicting outcomes for this patient subset are lacking. We aimed to develop and validate a nomogram to predict recurrence-free survival (RFS) and the benefits of adjuvant c...
Autores principales: | Lu, Jun, Xu, Bin-bin, Zheng, Chao-hui, Li, Ping, Xie, Jian-wei, Wang, Jia-bin, Lin, Jian-xian, Chen, Qi-yue, Truty, Mark J., Huang, Chang-ming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7643002/ https://www.ncbi.nlm.nih.gov/pubmed/33194683 http://dx.doi.org/10.3389/fonc.2020.574611 |
Ejemplares similares
-
Is Adjuvant Chemotherapy Beneficial to All Patients With pT3N0M0 Stage Gastric Cancer?
por: Huang, Jiao-Bao, et al.
Publicado: (2021) -
A novel nomogram predicting the early recurrence of hepatocellular carcinoma patients after R0 resection
por: Wang, Huanhuan, et al.
Publicado: (2023) -
Adjuvant Chemoradiotherapy Versus Adjuvant Chemotherapy for Stage III Gastric or Gastroesophageal Junction Cancer After D2/R0 Resection
por: Shi, Jinming, et al.
Publicado: (2022) -
Computed Tomography-Based Radiomics Nomogram: Potential to Predict Local Recurrence of Gastric Cancer After Radical Resection
por: Huang, Liebin, et al.
Publicado: (2021) -
Development and validation of nomogram models to predict radiotherapy or chemotherapy benefit in stage III/IV gastric adenocarcinoma with surgery
por: Ren, Xiangqing, et al.
Publicado: (2023)